Nanovaccine Based on a Biepitope Antigen to Potentiate the Immunogenicity of a Neoantigen.
Sign Up to like & getrecommendations! Published in 2023 at "ACS macro letters"
DOI: 10.1021/acsmacrolett.2c00742
Abstract: Specific neoantigens are promising candidates for personalized cancer vaccines and immunotherapies, whereas the low immunogenicity and physicochemical variability are the main challenges in clinical trials. Herein, based on the rational design of neoantigens, we developed… read more here.
Keywords: biepitope; neoantigen; immunogenicity; biepitope nanovaccines ... See more keywords